UP!
| Period | Date | Adjusted Actuals EPS | GAAP EPS |
|---|---|---|---|
| Q3 2022 | 2022-11-01 | Future report Set alerts | |
| Q2 2022 | 2022-08-09 | -0.55 | -0.55 |
| Q1 2022 | 2022-05-09 | -0.63 | -0.63 |
| Q4 2021 | 2022-02-28 | -0.54 | -0.54 |
| Q3 2021 | 2021-11-03 | -0.51 | -0.51 |
| Q2 2021 | 2021-08-09 | -0.62 | -0.62 |
| Q1 2021 | 2021-05-10 | -0.58 | -0.58 |
| Q4 2020 | 2021-02-24 | -0.68 | -0.68 |
| Q3 2020 | 2020-11-05 | 0.00 | 0.00 |
| Q2 2020 | 2020-08-05 | -0.61 | -0.61 |
| 2016-07-09 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-06-27 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-24 | Reiterated Rating | Cantor Fitzgerald | Buy | $41.00 |
| 2016-05-08 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2016-05-06 | Reiterated Rating | Brean Capital | Buy | $55.00 |
| 2016-05-02 | Initiated Coverage | Cantor Fitzgerald | Buy | $41.00 |
| 2016-04-28 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-04-20 | Reiterated Rating | Noble Financial | Buy | $51.00 |
| 2016-04-19 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-04-18 | Reiterated Rating | Jefferies Group | Buy | |
| 2016-04-18 | Reiterated Rating | Brean Capital | Buy | |
| 2016-04-17 | Reiterated Rating | Cowen and Company | Buy | $47.00 |
| 2016-03-07 | Reiterated Rating | Cowen and Company | Outperform | $47.00 |
| 2016-03-05 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-02-23 | Reiterated Rating | Noble Financial | Buy | $51.00 |
| 2016-02-20 | Reiterated Rating | Cowen and Company | Buy | $47.00 |
| 2016-02-19 | Reiterated Rating | Brean Capital | Buy | $55.00 |
| 2016-02-05 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-01-15 | Reiterated Rating | Leerink Swann | Buy | $56.00 |
| 2016-01-15 | Reiterated Rating | Brean Capital | Buy | |
| 2016-01-15 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-01-15 | Reiterated Rating | Lake Street Capital | Buy | $45.00 |
| 2016-01-07 | Reiterated Rating | Noble Financial | Buy | $51.00 |
| 2015-12-10 | Initiated Coverage | Lake Street Capital | Buy | $45.00 |
| 2015-11-11 | Reiterated Rating | Cowen and Company | Outperform | $47.00 |
| 2015-10-04 | Reiterated Rating | Brean Capital | Buy | |
| 2015-09-30 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-09-24 | Boost Price Target | Bank of America | Buy | $54.00 |
| 2015-09-24 | Reiterated Rating | Leerink Swann | Buy | |
| 2015-09-24 | Reiterated Rating | JMP Securities | Buy | |
| 2015-09-24 | Boost Price Target | Bank of America Corp. | Buy | $54.00 |
| 2015-09-23 | Boost Price Target | Leerink Swann | Outperform | $38.00 to $57.00 |
| 2015-09-23 | Reiterated Rating | Brean Capital | Buy | $45.00 to $55.00 |
| 2015-09-23 | Boost Price Target | JMP Securities | Market Outperform | $40.00 to $56.00 |
| 2015-09-23 | Reiterated Rating | Jefferies Group | Buy | $47.00 to $58.00 |
| 2015-09-02 | Initiated Coverage | Bank of America | Buy | $46.00 |
| 2015-08-19 | Boost Price Target | JMP Securities | $38.00 to $40.00 | |
| 2015-08-17 | Boost Price Target | Cowen and Company | Buy | $40.00 to $47.00 |
| 2015-08-10 | Reiterated Rating | Brean Capital | Buy | $45.00 |
| 2015-08-03 | Reiterated Rating | Brean Capital | Buy | $40.00 to $45.00 |
| 2015-07-23 | Reiterated Rating | Noble Financial | Buy | $29.00 to $41.00 |
| 2015-07-23 | Reiterated Rating | Cowen and Company | Buy | |
| 2015-06-30 | Boost Price Target | JMP Securities | Market Outperform | $25.00 to $33.00 |
| 2015-06-26 | Initiated Coverage | Cowen and Company | Outperform | $40.00 |
| 2015-06-19 | Boost Price Target | Leerink Swann | Outperform | $26.00 to $38.00 |
| 2015-05-29 | Reiterated Rating | Brean Capital | Buy | $40.00 |
| 2015-05-29 | Reiterated Rating | Leerink Swann | Outperform | $20.00 |
| 2015-05-29 | Boost Price Target | JMP Securities | Market Outperform | $23.00 to $25.00 |
| 2015-05-15 | Reiterated Rating | Brean Capital | Buy | $40.00 |
| 2015-03-20 | Reiterated Rating | Noble Financial | Buy | |
| 2015-03-20 | Initiated Coverage | Jefferies Group | Buy | $22.00 |
| 2015-03-18 | Boost Price Target | Leerink Swann | Outperform | $18.00 to $20.00 |
| 2015-03-13 | Reiterated Rating | Brean Capital | Buy | $40.00 |
| 2014-08-07 | Initiated Coverage | Noble Financial | Buy | $18.00 |
| 2014-05-09 | Lower Price Target | Jefferies Group | $20.00 to $18.00 | |
| 2014-03-06 | Boost Price Target | JMP Securities | Outperform | $16.00 to $20.00 |
| 2014-02-03 | Initiated Coverage | Leerink Swann | Outperform | |
| 2013-10-29 | Initiated Coverage | Brean Capital | Buy |
| 2016-07-09 | Reiterated Rating | Cowen and Company | Buy | |
| 2016-06-27 | Reiterated Rating | Leerink Swann | Buy | |
| 2016-06-24 | Reiterated Rating | Cantor Fitzgerald | Buy | $41.00 |
| 2016-05-08 | Reiterated Rating | Cantor Fitzgerald | Buy | |
| 2016-05-06 | Reiterated Rating | Brean Capital | Buy | $55.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In HRTX 148 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| FRANKLIN RESOURCES INC | 11.88M |
| BlackRock Inc. | 9.26M |
| STATE STREET CORP | 8.84M |
| Vanguard Group, Inc | 8.75M |
| BAKER BROS. ADVISORS LP | 8.13M |
| TANG CAPITAL MANAGEMENT LLC | 6.84M |
| JPMORGAN CHASE & CO | 6.69M |
| GREAT POINT PARTNERS LLC | 5.65M |
| Arrowpoint Asset Management, LLC | 5.60M |
| JANUS CAPITAL MANAGEMENT LLC | 5.50M |
| PALISADE CAPITAL MANAGEMENT LLC/NJ | 3.39M |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2.81M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.83M |
| GOLDMAN SACHS GROUP INC | 1.27M |
| ORBIMED ADVISORS LLC | 1.12M |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| TANG KEVIN C | 29.49% (8525215) | ARDM / CYCC / HRTX / LJPC / ODT / VNDA / |
| Baker Brothers Life Sciences Capital (GP), LLC | 18.22% (5266568) | HRTX / OCRX / |
| Whelan John CFO | 0.88% (254088) | HRTX / |
| TURNBULL GREG President, CEO and Director | 0.85% (245092) | HRTX / PLNR / |
| GODDARD PAUL Chairman of the Board | 0.74% (214683) | HRTX / |
| ROSENBLATT TOBY | 0.73% (210234) | HRTX / |
| ZERBE ROBERT L MD | 0.70% (202072) | ASTM / HRTX / |
| Rosen Robert SVP & Chief Commercial Officer | 0.36% (102640) | HRTX / LJPC / |
| Quart Barry D Chief Executive Officer | 0.24% (67993) | GEVA / HRTX / |
| PRENTKI RONALD J President & CEO | 0.14% (40539) | HRTX / |
| DAVIS STEPHEN | 0.07% (20076) | ACAD / FURX / GEVA / HRTX / |
| TAYLOR ARTHUR T | 0.04% (12000) | HRTX / |
| POYHONEN JOHN | 0.03% (10000) | HRTX / SNMX / |
| RIEPENHAUSEN PETER | 0.03% (9000) | HRTX / |
| Drazba Brian G. VP, Finance & CFO | 0.01% (3798) | HRTX / MEIP / |
| Marshall Paul SVP, Technical Operations | 0.01% (2200) | HRTX / |
UM